SPECT全身核素骨显像对肺癌骨转移诊断的临床价值  

Clinical Application of SPECU Bone Imaging in Diagnosing Bone Metastasis from Lung Cancer

作　　者：饶国辉[1] 李纬明[1] 李春亿[1] 吴克宁[1] 岳殿超[1] 胡平[1] 

机构地区：[1]广东省广州市中山大学附属第一医院核医学科,510080

出　　处：《实用全科医学》2008年第6期568-569,共2页Applied Journal Of General Practice

摘　　要：目的探讨核素骨显像诊断早期肺癌骨转移的临床价值。方法对186例确诊的肺癌患者进行99mTc-MDP骨显像,对骨转移的部位、数量与病理类型进行回顾性分析。结果肺癌骨转移发生率为60.22%,骨转移灶的分布以胸部骨最多见(43.11%),其次脊柱(26.48%)和骨盆(19.16%),四肢骨(9.02%)和颅骨等其他骨骼(2.23%)最少。肺腺癌较其他类型肺癌更易发生骨转移。结论肺癌骨转移发生率较高,全身核素骨显像对骨转移的诊断有价值,应作为肺癌的常规检查。Objective To evaluate the clinical value of SPECT bone imaging in diagnosing bone metastasis from lung cancer. Methods 186 patients with diagnosed lung cancer were examined by 99mTe-MDP bone imaging,and the bone metastatic sites, quantity and pathological types of those with skeletal metastases were retrospectively analyzed. Results The incidence of bone metastses was 60.22 %. the thoracic bones were the most frequent metastatic sites, spinal and pelvic bone were the next. The skeletal metastaese of adenocarcinoma was more easily than other types of cancer. Conclusions Bone metastasis in patients with lung cancer is an often event. SPECT bone imaging should be routinely performed in patients with lung cancer,because it is of importance for evaluation in diagnosing bone metastasis.

关 键 词：肺肿瘤 骨转移 单光子发射计算机断层显像术 核素骨显像 

分 类 号：R734.2[医药卫生—肿瘤] R817.4[医药卫生—临床医学]